Literature DB >> 7632940

Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "switch" cultures.

M E Lemieux1, V I Rebel, P M Lansdorp, C J Eaves.   

Abstract

In this report, we describe a modification of the assay for long-term culture-initiating cells (LTC-IC) that allows a subset of murine LTC-IC (designated as LTC-ICML) to express both their myeloid (M) and lymphoid (L) differentiative potentials in vitro. The modified assay involves culturing test cells at limiting dilutions on irradiated mouse marrow feeder layers for an initial 4 weeks under conditions that support myelopoiesis and then for an additional week under conditions permissive for B-lymphopoiesis. All of the clonogenic pre-B progenitors (colony-forming unit [CFU] pre-B) detected in such postswitch LTC appear to be the progeny of uncommitted cells present in the original cell suspension because exposure of lymphoid-restricted progenitors to myeloid LTC conditions for > or = 7 days was found to irreversibly terminate CFU-pre-B production and, in cultures initiated with limiting numbers of input cells (no progenitors of any type detected in > 70% of cultures 1 week after the switch), the presence of CFU-pre-B was tightly associated with the presence of myeloid clonogenic cells, regardless of the purity of the input population. Limiting dilution analysis of the proportion of negative cultures measured for different numbers of input cells showed the frequency of LTC-ICML in normal adult mouse marrow to be 1 per 5 x 10(5) cells with an enrichment of approximately 500-fold in the Sca-1+ Lin-WGA+ fraction, as was also found for competitive in vivo repopulating units (CRU) and conventionally defined LTC-IC. LTC-ICML also exhibited the same resistance to treatment in vivo with 5-fluorouracil (5-FU) as CRU and LTC-IC, thereby distinguishing these three populations from the great majority of both in vitro clonogenic cells and day 12 CFU-S. The ability to quantitate cells with dual lymphoid and myeloid differentiation potentials in vitro, without the need for their prior purification, should facilitate studies of totipotent hematopoietic stem cell regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632940

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta.

Authors:  Marion Roques; Charles Durand; Rodolphe Gautier; Pierre-Yves Canto; Laurence Petit-Cocault; Laurent Yvernogeau; Dominique Dunon; Michèle Souyri; Thierry Jaffredo
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

Review 3.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

4.  Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Authors:  A L Petzer; D E Hogge; P M Landsdorp; D S Reid; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice.

Authors:  Safak Yalcin; Dragan Marinkovic; Sathish Kumar Mungamuri; Xin Zhang; Wei Tong; Rani Sellers; Saghi Ghaffari
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

6.  Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability.

Authors:  C L Miller; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Mitochondrial metabolism in hematopoietic stem cells requires functional FOXO3.

Authors:  Pauline Rimmelé; Raymond Liang; Carolina L Bigarella; Fatih Kocabas; Jingjing Xie; Madhavika N Serasinghe; Jerry Chipuk; Hesham Sadek; Cheng Cheng Zhang; Saghi Ghaffari
Journal:  EMBO Rep       Date:  2015-07-24       Impact factor: 8.807

8.  Cytokine manipulation of primitive human hematopoietic cell self-renewal.

Authors:  P W Zandstra; E Conneally; A L Petzer; J M Piret; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

Review 9.  The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles.

Authors:  Peter J Quesenberry; Jason M Aliotta
Journal:  Stem Cell Rev       Date:  2008-07-30       Impact factor: 5.739

10.  Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.

Authors:  S L Kirby; D N Cook; W Walton; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.